IPERIONX (IPX) director files initial insider ownership report

Rhea-AI Filing Summary

IPERIONX Ltd director Martin Lorraine M filed an initial ownership report showing a substantial stake in the company. The filing lists direct beneficial ownership of 1,177,138 Ordinary Shares and 90,216 Restricted Stock Units.

Of the RSUs, 76,054 are scheduled to vest in December 2026 and 14,162 in December 2027. IPX Ordinary Shares trade on the Australian Stock Exchange.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Martin Lorraine M

(Last) (First) (Middle)

1092 CONFROY DRIVE

(Street)

SOUTH BOSTON VIRGINIA 24592

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
IPERIONX Ltd [ IPX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(1)	1,177,138	D
Restricted Stock Units	90,216(2)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. IPX Ordinary Shares trade on the Australian Stock Exchange (ASX)

2. 76,054 vest in December 2026; 14,162 vest in December 2027

	Samantha Birdsong Manning	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the IPERIONX (IPX) Form 3 filing report for Martin Lorraine M?

The Form 3 reports Martin Lorraine M’s initial beneficial ownership in IPERIONX Ltd, including Ordinary Shares and Restricted Stock Units. It establishes his baseline holdings as a director at the time he became subject to insider reporting requirements.

How many IPERIONX (IPX) Ordinary Shares does Martin Lorraine M hold?

Martin Lorraine M directly holds 1,177,138 IPERIONX Ordinary Shares according to the Form 3. This figure reflects his direct beneficial ownership and serves as the reference point for future Form 4 or Form 5 transaction disclosures.

What Restricted Stock Units (RSUs) are reported for IPERIONX (IPX) director Martin Lorraine M?

The filing shows 90,216 Restricted Stock Units held by Martin Lorraine M. Of these, 76,054 RSUs are scheduled to vest in December 2026 and 14,162 are scheduled to vest in December 2027, providing a structured future equity entitlement.

When do the Restricted Stock Units for IPERIONX (IPX) director vest?

The Form 3 notes two RSU vesting tranches for Martin Lorraine M. 76,054 Restricted Stock Units are expected to vest in December 2026, and an additional 14,162 units are expected to vest in December 2027, subject to applicable plan terms.

On which exchange do IPERIONX (IPX) Ordinary Shares trade?

The footnotes specify that IPERIONX Ordinary Shares trade on the Australian Stock Exchange (ASX). This means the company’s primary listing for its Ordinary Shares is in Australia, even though insider ownership is reported to U.S. regulators.

Does the IPERIONX (IPX) Form 3 show any recent insider buying or selling?

No specific buy or sell transactions are detailed; the Form 3 functions as an initial ownership snapshot. It lists the number of Ordinary Shares and Restricted Stock Units held, without reporting any contemporaneous purchases or sales by the director.